Pandemic Forces F.D.A. to Sharply Curtail Drug Company Inspections

The steep decline in oversight has stalled a number of new drug applications. The agency says it is trying to protect its employees but critics say inspectors should be considered essential workers and do their jobs.

View original article
Contributor: Sheila Kaplan